Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?
Papamichael, Konstantinos, and Adam S Cheifetz. 2025. “Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?”. Alimentary Pharmacology & Therapeutics 61 (2): 369-70.